Late-life treatment with the GLP-1 receptor agonist semaglutide extended lifespan, preserved physical function, and improved memory in female mice.
“In the separate three-month experiment, semaglutide-treated mice had better spatial memory, coordination, muscle performance, endurance, and glucose control than saline-treated mice. The coordination and muscle-performance advantages remained after accounting for body weight.”